Company Lophos Holdings Inc.

Equities

MESC

CA5439371066

Biotechnology & Medical Research

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Other Biotechnology & Medical Research

Market Closed - Canadian Securities Exchange Other stock markets 09:56:14 21/05/2024 pm IST			5-day change	1st Jan Change
0.055 ^CAD	0.00%		+10.00%	+37.50%

15/04	ThreeD Capital Inc. announced that it expects to receive CAD 0.1275 million in funding from Lophos Holdings Inc.	CI
15/04	ThreeD Capital Inc. entered into a securities purchase agreement to acquire 2.5% stake in Lophos Holdings Inc. for CAD 0.05 million.	CI

Lophos Holdings Inc. is a Canada-based company, which is engaged in the cultivation and research of Lophophora williamsii (peyote cactus). The Company is also engaged in the research and development of compounds derived from the peyote cactus. The Company's cultivated peyote cactus will be used by the Company to conduct pre-clinical research and development in Canada either directly through a Controlled Substance Dealers License (CSDL) at its Napanee facility, or indirectly with one or more third-party partners. The Company's CSDL licensing includes the development of intellectual property related to the chemical composition of peyote and the custom formulation of Mescaline and related compounds and the research and development of drug delivery systems for Mescaline and other related molecules. It also operates a Health Canada licensed analytical testing and research and development institution, to conduct pre-clinical research and development through Sigma Analytical Services Inc.

Managers	Title	Age	Since
Jacqueline Claire Lupo CEO	Chief Executive Officer	39	23/21/23
Remantra Sheopaul DFI	Director of Finance/CFO	37	06/22/06

Members of the board	Title	Age	Since
Elyssia Patterson BRD	Director/Board Member	38	23/21/23
Solomon Elimimian BRD	Director/Board Member	38	14/20/14
Jacqueline Claire Lupo CEO	Chief Executive Officer	39	23/21/23
Jeremy Pestun BRD	Director/Board Member	46	01/22/01
Evan Stawnyczy BRD	Director/Board Member	48	01/22/01

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	85,859,673	71,258,918 ( 82.99 %)	0	82.99 %

Name	Equities	%	Valuation
Jacqueline Claire Lupo 14.90 %	11,000,000	14.90 %	660 000 $
John Karagiannidis 5.553 %	4,100,000	5.553 %	246 000 $
Evan Stawnyczy 0.001023 %	755	0.001023 %	45 $
Jeremy Pestun 0.000000 %	0	0.000000 %	- $

Lophos Holdings, Inc.

1111 Melville Street Suite 620

V6E 3V6, Vancouver

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
LOPHOS HOLDINGS INC.	+37.50%	3.45M
MODERNA, INC.	+64.23%	62.59B
IQVIA HOLDINGS INC.	-2.31%	41.18B
LONZA GROUP AG	+45.38%	40.29B
CELLTRION, INC.	-8.29%	27.9B
ICON PUBLIC LIMITED COMPANY	+11.97%	26.21B
ALNYLAM PHARMACEUTICALS, INC.	-21.16%	19.09B
BIO-TECHNE CORPORATION	+7.54%	13.08B
MEDPACE HOLDINGS, INC.	+27.17%	12.05B
UNITED THERAPEUTICS CORPORATION	+25.72%	12.26B

Other Biotechnology & Medical Research